I2PETPG - Imidazoline2 Binding Sites in a Group of Participants Diagnosed With AD

NCT02874820 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Patient recruitment issues.

Conditions

Alzheimer Disease

Interventions

RADIATION: [11C]BU99008
DRUG: Idazoxan

Sponsor

Imperial College London

Collaborators

[object Object]